Remove 2006 Remove Drug Pricing Remove Pharmaceutical Companies
article thumbnail

STAT+: Teva agrees to pay $450 million to settle kickback and price-fixing allegations

STAT

Separately, the drugmaker agreed to pay $25 million to settle charges of participating in a price-fixing scheme with other generic companies. At the same time, Teva steadily raised the price of its drug by thousands of dollars. At the same time, Teva steadily raised the price of its drug by thousands of dollars.

article thumbnail

Latest CMS Data Reveal the Truth About U.S. Drug Spending

Drug Channels

And contrary to what you might read, drug spending growth was *not* driven by purportedly “skyrocketing” drug prices. In reality, nearly all drug spending growth occurred due to growth in the number of people treated, prescriptions dispensed, and other nonprice factors. healthcare expenditures. healthcare expenditures.

article thumbnail

Informa Connect’s Compliance Congress for Specialty Products

Drug Channels

Drug Channels, or any of its employees. To find out how you can reach the Drug Channels audience, please contact Paula Fein (paula@DrugChannels.net). Copyright © 2006-2021 Pembroke Consulting, Inc. d/b/a Drug Channels Institute. Drug Channels® is a registered trademark of Pembroke Consulting, Inc.